Type to search

Bioscience and pharmaceutical Commercial Real Estate Government Health Care Insider Only News

Exclusive: Prelude gets $5.5M to double workforce, expand labs

Share

WILMINGTON – Cancer research company Prelude Therapeutics recently secured $5.5 million in state taxpayer-backed grants to move to new, larger labs and more than double its workforce in the state. The recent infusion of state dollars, the third time that Delaware has doled out public funds to support the growth of the company, came just

Want to Read More?

Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In.

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Limited time offer. New subscribers only.

Flash Sale! Subscribe to Delaware Business Times and save 50%.

Limited time offer. New subscribers only.